STOCK ALARM
SA
Menu
Demo
Log In
Atlas
News
Feed
Alerts
Portfolio
Screener
Picks
Charts
Economy
Movers
Regime
Earnings
Updates
ABT
(ABT)
ABT
Overview
Stream
Notebook
Intel
Chart
History
Fundamentals
TTM
Earnings
Analysts
News
Financials
Segments
Insiders
Institl.
DCF
Peers
Key Metrics
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$218.88B
+11.7%
P/E Ratio
33.50
+127.2%
P/S Ratio
4.94
+5.8%
ROE
12.51%
-55.5%
ROIC
8.43%
-14.7%
FCF Yield
3.38%
+4.2%
Debt/Equity
0.29
-9.8%
Current Ratio
1.58
-5.7%
Interest Coverage
23.60x
+108.5%
Per Share
Revenue/Share
$25.37
+4.7%
Net Income/Share
$3.73
-51.7%
Operating CF/Share
$5.48
+10.8%
Free CF/Share
$4.23
+15.4%
Cash/Share
$5.12
+11.2%
Book Value/Share
$30.21
+9.2%
Tangible Book/Share
$13.29
+26.8%
Equity/Share
$29.84
+8.4%
Interest Debt/Share
$8.82
-3.8%
Valuation
Market Cap
$218.88B
+11.7%
Enterprise Value
$225.43B
+10.8%
P/E Ratio
33.50
+127.2%
P/S Ratio
4.94
+5.8%
P/OCF Ratio
22.88
-0.0%
P/FCF Ratio
29.60
-4.0%
P/B Ratio
4.20
+2.2%
P/TB Ratio
4.20
+2.2%
EV/Sales
5.09
+4.8%
EV/EBITDA
19.51
+3.9%
Profitability
Earnings Yield
2.98%
-56.4%
FCF Yield
3.38%
+4.2%
ROE
12.51%
-55.5%
ROIC
8.43%
-14.7%
Return on Tangible Assets
11.42%
-56.0%
Capital Allocation
CapEx/OCF
22.69%
-12.0%
CapEx/Revenue
4.90%
-6.9%
CapEx/Depreciation
0.70
+1.6%
SBC/Revenue
1.50%
-6.6%
Balance Sheet
Debt/Equity
0.29
-9.8%
Debt/Assets
0.17
-7.4%
Net Debt/EBITDA
0.57
-19.9%
Current Ratio
1.58
-5.7%
Interest Coverage
23.60x
+108.5%
Income Quality
1.47
+129.6%
Efficiency
Days Sales Outstanding
65 days
+8.4%
Days Payables Outstanding
78 days
+5.7%
Days Inventory
120 days
+9.5%
Receivables Turnover
5.59x
-7.7%
Payables Turnover
4.65x
-5.4%
Inventory Turnover
3.04x
-8.7%
Special Valuations
Graham Number
$50.07
-27.7%
Graham Net-Net
$-9.05
+9.2%
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Home
Screener
Alerts
Search
More
Abbott Laboratories
(ABT)
$111.26
—
Chart
Share
Post on X
ABT
Abbott Laboratories
(ABT)
NYSE
$111.26
—
Chart Studio
Share
ABT